Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:36 PM
Ignite Modification Date:
2025-12-24 @ 1:36 PM
NCT ID:
NCT07206095
Eligibility Criteria:
Inclusion Criteria:
* Patients sustaining a confirmed or suspected diagnosis of an hereditary rare hemolytic anemia:
* Sickle cell disease
* Thalassemic syndromes
* Congenital dyserythropoietic anemia
* Enzymopathy
* Unstable Hemoblogin / Altered oxygen affinity
* Hereditary stomatocytosis
* Hereditary pyropoikilocytosis
* Hereditary spherocytosis with severe anemia (\<8 g/dL) or inconclusive diagnosis:
* Patient with chronic hemolytic anemia and red cell smear compatible, but with:
* EMA binding test: inconclusive or negative
* Genetic testing: no definitive diagnosis (VUS or no findings)
* Not transplanted or undergoing gene therapy at the time of inclusion. Patients with graft failure without a new transplant may be included.
Exclusion Criteria:
* Carrier traits in autosomal recessive hereditary anemias
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT07206095
Study Brief:
Protocol Section:
NCT07206095